Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.10% | $220.49M | €401.77B | 41.34% | 76 Outperform | |
| Roche Holding AG | 1.94% | $137.98M | CHF270.15B | 45.02% | 73 Outperform | |
| AstraZeneca | 1.92% | $136.54M | £220.54B | 29.01% | 80 Outperform | |
| HSBC Holdings | 1.79% | $127.84M | £204.52B | 48.96% | 80 Outperform | |
| Novartis AG | 1.75% | $124.86M | CHF216.20B | 24.14% | 80 Outperform | |
| SAP SE | 1.66% | $118.13M | €237.28B | -15.64% | 66 Neutral | |
| Nestlé SA | 1.56% | $111.41M | CHF188.36B | 12.31% | 71 Outperform | |
| Siemens | 1.48% | $105.60M | €199.94B | 30.63% | 74 Outperform | |
| Shell (UK) | 1.35% | $96.16M | £151.07B | -1.97% | 73 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.19% | $85.01M | €312.82B | -1.45% | 78 Outperform |